Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

Ku CL, Picard C, Erdös M, Jeurissen A, Bustamante J, Puel A, von Bernuth H, Filipe-Santos O, Chang HH, Lawrence T, Raes M, Maródi L, Bossuyt X, Casanova JL.

J Med Genet. 2007 Jan;44(1):16-23. Epub 2006 Sep 1.

2.

Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.

Bustamante J, Boisson-Dupuis S, Jouanguy E, Picard C, Puel A, Abel L, Casanova JL.

Curr Opin Immunol. 2008 Feb;20(1):39-48. Review.

PMID:
18083507
3.

Recurrent systemic pneumococcal disease in children.

Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, Givner LB, Hoffman J, Kaplan SL.

Pediatr Infect Dis J. 2007 Jun;26(6):480-4.

PMID:
17529863
4.

Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling.

Currie AJ, Davidson DJ, Reid GS, Bharya S, MacDonald KL, Devon RS, Speert DP.

J Pediatr. 2004 Apr;144(4):512-8.

PMID:
15069402
5.

Recurrent systemic pneumococcal disease and IRAK4 deficiency.

Turvey SE, Speert DP.

Pediatr Infect Dis J. 2007 Nov;26(11):1074; author reply 1074. No abstract available.

PMID:
17984826
6.

Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Ellis MK, Elliott KS, Rautanen A, Crook DW, Hill AV, Chapman SJ.

PLoS One. 2015 Apr 17;10(4):e0123532. doi: 10.1371/journal.pone.0123532. eCollection 2015.

7.

Heritable defects of the human TLR signalling pathways.

Puel A, Yang K, Ku CL, von Bernuth H, Bustamante J, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C, Casanova JL.

J Endotoxin Res. 2005;11(4):220-4. Review.

PMID:
16176658
8.

Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae.

Trumstedt C, Eriksson E, Lundberg AM, Yang TB, Yan ZQ, Wigzell H, Rottenberg ME.

J Leukoc Biol. 2007 Jun;81(6):1591-8. Epub 2007 Mar 14.

PMID:
17360955
9.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
10.

Inherited disorders of human Toll-like receptor signaling: immunological implications.

Ku CL, Yang K, Bustamante J, Puel A, von Bernuth H, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C, Casanova JL.

Immunol Rev. 2005 Feb;203:10-20. Review.

PMID:
15661018
11.

IRAK4 in TLR/IL-1R signaling: possible clinical applications.

Li X.

Eur J Immunol. 2008 Mar;38(3):614-8. doi: 10.1002/eji.200838161.

12.

Recurrent infection with genetically identical pneumococcal isolates in a patient with interleukin-1 receptor-associated kinase-4 deficiency.

Szabó J, Dobay O, Erdos M, Borbély A, Rozgonyi F, Maródi L.

J Med Microbiol. 2007 Jun;56(Pt 6):863-5.

PMID:
17510276
13.

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health.

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.

PMID:
19935447
14.

Immunodeficiency among children with recurrent invasive pneumococcal disease.

Ingels H, Schejbel L, Lundstedt AC, Jensen L, Laursen IA, Ryder LP, Heegaard NH, Konradsen H, Christensen JJ, Heilmann C, Marquart HV.

Pediatr Infect Dis J. 2015 Jun;34(6):644-51. doi: 10.1097/INF.0000000000000701.

16.

Recurrent invasive pneumococcal disease in children: underlying clinical conditions, and immunological and microbiological characteristics.

Alsina L, Basteiro MG, de Paz HD, Iñigo M, de Sevilla MF, Triviño M, Juan M, Muñoz-Almagro C.

PLoS One. 2015 Mar 4;10(3):e0118848. doi: 10.1371/journal.pone.0118848. eCollection 2015.

17.

A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.

Kim TW, Staschke K, Bulek K, Yao J, Peters K, Oh KH, Vandenburg Y, Xiao H, Qian W, Hamilton T, Min B, Sen G, Gilmour R, Li X.

J Exp Med. 2007 May 14;204(5):1025-36. Epub 2007 Apr 30.

18.
19.

Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.

Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R.

Pediatr Infect Dis J. 2009 Apr;28(4):277-82. doi: 10.1097/INF.0b013e31818e0e2e.

PMID:
19258924
20.

Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease.

Carrasco-Colom J, Jordan I, Alsina L, Garcia-Garcia JJ, Cambra-Lasaosa FJ, Martín-Mateos MA, Juan M, Muñoz-Almagro C.

Pediatr Infect Dis J. 2015 Sep;34(9):1008-13. doi: 10.1097/INF.0000000000000779.

PMID:
26075815

Supplemental Content

Support Center